Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06305624 · ClinicalTrials.gov registry record · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
A NA study of Alcohol Use Disorder and Alcohol-related Liver Disease, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 298
- Enrollment target
- 3
- Study locations
NCT06305624: Recruiting NA study of Alcohol Use Disorder and Alcohol-related Liver Disease, sponsored by University of Wisconsin, Madison.
NCT06305624 is a NA study of Alcohol Use Disorder and Alcohol-related Liver Disease that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 298 participants, roughly in line with the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target. The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06305624, a NA study of Alcohol Use Disorder and Alcohol-related Liver Disease, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 298 participants
- Enrollment target
- 3
- Study locations
Study Summary
This protocol describes a randomized controlled trial testing the effectiveness and implementability of the CHESS Health Connections smartphone application among patients with alcohol-associated liver disease (ALD) at two medical centers in Michigan and Wisconsin, in two types of clinics: general hepatology and multidisciplinary that offers care for advanced ALD alongside co-located, integrated mental health and substance abuse treatment. The long-term goal of this and future work is to prevent disease progression and promote healthy behaviors by improving the rate of abstinence among patients with ALD earlier in the course of their disease. 298 participants will be enrolled and can expect to be on study for up to 6 months.
Primary Outcome
Alcohol consumption outcomes will be collected monthly and include whether or not alcohol was consumed on each of the past 30 days. Alcohol consumption outcomes will be compared between the usual care condition and the usual care plus the Connections app condition.
Conditions Studied
Interventions
- DEVICE Connections App
Study Locations (3)
Wisconsin
- UW General Hepatology Clinic - Madison
- UW Multidisciplinary ALD Clinic - Madison
Michigan
- Henry Ford + Michigan State University Health Center - Lansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2027-10-31 |
| Phase | NA |
What NCT06305624 shows while recruiting
NCT06305624 is an interventional study that assigns participants to a tested intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target.
The record links to 2 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Connections App is the first listed.
NCT06305624 reports a single indexed study location in Wisconsin, Michigan.
Frequently Asked Questions
What is clinical trial NCT06305624 about?
NCT06305624 is a clinical study titled "Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease". This protocol describes a randomized controlled trial testing the effectiveness and implementability of the CHESS Health Connections smartphone application among patients with alcohol-associated liver disease (ALD) at two medical centers in Michigan and Wisconsin, in two types of clinics: general he...
What is the current status of trial NCT06305624?
This trial is currently recruiting. It is a NA study. The enrollment target is 298 participants. The study started on 2024-06-01. Estimated completion is 2027-10-31.
What conditions does trial NCT06305624 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol-related Liver Disease.
What interventions are being tested in trial NCT06305624?
The interventions under investigation include: Connections App (DEVICE).
Who is sponsoring clinical trial NCT06305624?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06305624 being conducted?
This trial has 3 study locations across Michigan, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06305624's enrollment target sits among peer trials
298 30th of 184 higher than 155 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06754215 · 298 participants · NA
Smoking Cessation Intervention Development for Homeless Youth
- NCT06780111 · 298 participants · Phase 1
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
- NCT07209358 · 298 participants · NA
EDX110 Randomized Control Trial for Treatment of DFUs
- NCT06309160 · 297 participants · NA
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI